期刊文献+

82例急性早幼粒细胞白血病形态学及免疫表型特征分析 被引量:2

Acute promyelocytic leukemia cell morphology and immune phenotypic characteristics:An analysis of 82 cases
下载PDF
导出
摘要 目的探讨急性早幼粒细胞白血病(acute promyelocytic leukemia,APL)患者的细胞形态及免疫表型特点。方法选取2010年8月-2014年3月于解放军总医院就诊的APL患者82例,采用流式细胞仪免疫荧光技术检测其白血病细胞免疫表型,并结合骨髓细胞形态检查进行分析。结果流式细胞分析应用CD45/SSC双参数散点图证实APL患者异常早幼粒细胞比例为45.6%-88.2%,形态学检查异常早幼粒细胞比例为50.5%-94.5%。其抗原阳性表达率及平均阳性细胞比例:CD33(100%、90.2%),CD13(100%、85.3%),CD9(85.4%、68.2%),CD64(91.5%、67.4%),CD117(65.9%、56.4%),CD2(11.0%、36.2%),CD11b(18.3%、30.5%),CD16(0.0%、0.0%),CD19(3.7%、26.3%),CD15(9.8%、44.6%),CD4(0.0%、0.0%),CD56(17.1%、41.7%),CD34(9.8%、40.4%),CD3(0.0%、0.0%),CD7(4.9%、34.2%),CD10(0.0%、0.0%),CD14(0.0%、0.0%),CD20(0.0%、0.0%),HLA-DR(12.2%、42.4%)。CD34^+和(或)HLA-DR^+组表达CD2、CD56抗原强度明显高于CD34^-和HLA^-DR-组(P〈0.05)。M3a型CD117抗原阳性表达率明显高于M3v型(P〈0.05),M3v型CD34抗原阳性表达率明显高于M3a和M3b型(P〈0.01)。结论骨髓细胞形态学是诊断APL的基础,结合其免疫表型有助于提高确诊率及分析白血病细胞来源。 Objective To study the cell morphologic and immunophenotypic characteristics of patients with acute promyelocytic leukemia(APL). Methods Flow cytometry instrument immunofluorescence technique was used to detect the immune phenotype of leukemic cells in 82 patients with APL, and bone marrow cell morphology inspection was also applied. Results The proportion of abnormal promyelocyte detected by morphologic examination was 50.5%- 94.5%, the proportion of abnormal promyelocyte detected by CD45/SSC gating was 45.6%- 88.2%. The antigen positive expression rate and the average ratio of positive cells were as follows: CD33(100%, 90.2%), CD13(100%, 85.3%), CD9(85.4%, 68.2%), CD64(91.5%, 67.4%), CD117(65.9%, 56.4%), CD2(11.0%, 36.2%), CD11b(18.3%, 30.5%), CD16(0.0%, 0.0%), CD19(3.7%, 26.3%), CD15(9.8%, 44.6%), CD4(0.0%, 0.0%), CD56(17.1%, 41.7%), CD34(9.8%, 40.4%), CD3(0.0%, 0.0%), CD7(4.9%, 34.2%), CD10(0.0%, 0.0%), CD14(0.0%, 0.0%), CD20(0.0%, 0.0%.), HLA-DR(12.2%, 42.4%). CD2 and CD56 antigen expression was significantly higher in CD34^+ and/or HLA-DR^+group than in CD34^- and HLA-DR^- group(P〈0.05). M3 a type CD117 positive antigen expression rate was significantly higher than M3 v type(P〈0.05), M3 v type CD34 positive antigen expression rate was significantly higher than M3 a and M3 b type(P〈 0.01). Conclusion Bone marrow cell morphology is the basis of the diagnosis of APL, and it will be helpful in improving the diagnosis accuracy and analysis of the source of leukemia cells if combing with immunophenotype.
出处 《解放军医学院学报》 CAS 2015年第8期789-793,共5页 Academic Journal of Chinese PLA Medical School
关键词 急性早幼粒细胞白血病 细胞形态学 免疫表型 acute promyelocytic leukemia cell morphology immunephenotype
  • 相关文献

参考文献16

  • 1Wang ZY, Chen Z. Acute promyelocytic leukemia : from highly fatal to highly curable [ J ]. Blood, 2008, 111 ( 5 ) : 2505-2515.
  • 2徐晓兰,范志平,宋兰林,林榕,刘启发.伴t(11;17)(q23;q21)易位的急性早幼粒细胞白血病1例并文献复习[J].南方医科大学学报,2007,27(6):923-924. 被引量:3
  • 3常晓丽,董征,刘莎,姚波,满秋红,刘铁强,李玉芳,刘志强,刘广贤,艾辉胜,郭梅.伴t(11;17)(q23;q21)易位的急性早幼粒细胞白血病1例并文献复习[J].解放军医学杂志,2013,38(5):378-382. 被引量:6
  • 4Kaleem Z, Crawford E, Pathan MH, et al. Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data [ J ] . Arch Pathol Lab Med, 2003, 127 ( 1 ) : 42-48.
  • 5Paietta E. Expression of cell-surface antigens in acute promyelocytic leukaemia [ J ] . Best Pract Res Ctin Haematol, 2003, 16 ( 3 ) : 369-385.
  • 6Rizzatti EG, Garcia AB, Portieres FL, et al. Expression of CDl17 and CDllb in bone marrow can differentiate acute promyelocytic leukemia from recovering benign myeloid proliferation [ J ] . Am J Clin Pathol, 2002, 118 ( 1 ) : 31-37.
  • 7Montesinos P, Ray 6 n C, Vellenga E, et al. Clinical significance of CD56 expression in patients with acute promyelocytic leukemiatreated with all-trans retinoic acid and anthracycline-based regimens [ J ]. Blood, 2011, 117 ( 6 ) : 1799-1805.
  • 8Breccia M, De Propris MS, Minotti C, et al. Aberrant phenotypic expression of CD15 and CD56 identifies poor prognostic acute promyelocytic leukemia patients [ J 1 - Leuk Res, 2014, 38 ( 2 ) : 194-197.
  • 9Percherancier Y, Germain-Desprez D, Galisson F, et al. Role of SUMO in RNF4-mediated promyelocytic leukemia protein ( PML ) degradation : sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells [ J ] . J Biol Chem, 2009, 284 (24) : 16595-16608.
  • 10Ahmad El, Akl HKh, Hashem ME, et al. The biological characteristics of adult CD34+ acute promyeloeytic leukemia [ J ] . Med Oneol, 2012, 29 (2) : 1119-1126.

二级参考文献54

  • 1车春兰,杨天楹.233例急性非淋巴细胞白血病分型的探讨[J].中华血液学杂志,1989,10(1):24-26. 被引量:8
  • 2金波,于萍,侯科佐,刘云鹏.三氧化二砷治疗急性早幼粒细胞白血病过程中高白细胞血症和维甲酸综合征的特点[J].中华肿瘤防治杂志,2006,13(8):614-617. 被引量:5
  • 3Chen Z,Brand NJ,Chen A,et al.Fusion between a novel Kruppellike zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t (11;17) translocation associated with acute promyelocytic leukaemia[J].Embo J,1993,12:1161-7.
  • 4Grimwade D,Biondi A,Mozziconacci MJ,et al.Characterization of acute promyelocytic leukemia cases lacking the classic t (15; 17):results of the European Working Party Group[J].Blood,2000,96(4):1297-308.
  • 5Sainty D,Liso V,Cantu-Rajnoldi A,et al.A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements[J].Blood,2000,96(4):1287-96.
  • 6Licht JD,Chomienne C,Goy A,et al.Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17)[J].Blood,1995,85(3):1083-94.
  • 7Koken MH,Daniel MT,Gianni M,et al.Retinoic acid,but not arsenic trioxide,degrades the PLZF/RAR alpha fusion protein,without inducing terminal differentiation or apoptosis,in a RA-therapy resistant t(11; 17)(q23 ;q21) APL patient[J].Oncogene,1999,18(4):1113-8.
  • 8Jansen JH,Lowenberg B.Acute promyelocytic leukemia with a PLZFRARalpha fusion protein[J].Semin Hematol,2001,38(1):37-41.
  • 9Guidez P,Huang W,Tong JH,et al.Poor response to all-trans retinoic acid therapy in a t(11; 17)PLZF/RARα patient[J].Leukemia,1994,8(2):312.
  • 10Lallemand-Breitenbach V, Zhu J, Chen Z, et al. Curing APL through PML/RARA degradation by As,O3[J]. Trends Mol Med, 2012, 18(1): 36-42.

共引文献15

同被引文献29

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部